Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

Alaide Chieffo; Dariusz Dudek; Christian Hassager; Alain Combes; Mario Gramegna; Sigrun Halvorsen; Kurt Huber; Vijay Kunadian; Jiri Maly; Jacob Eifer Møller; Federico Pappalardo; Giuseppe Tarantini; Guido Tavazzi; Holger Thiele; Christophe Vandenbriele; Nicolas Van Mieghem; Pascal Vranckx; Nikos Werner; Susanna Price

doi:10.4244/eijy21m05_01

Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

Alaide Chieffo^*, Dariusz Dudek, Christian Hassager, Alain Combes, Mario Gramegna, Sigrun Halvorsen, Kurt Huber, Vijay Kunadian, Jiri Maly, Jacob Eifer Møller, Federico Pappalardo, Giuseppe Tarantini, Guido Tavazzi, Holger Thiele, Christophe Vandenbriele, Nicolas Van Mieghem, Pascal Vranckx, Nikos Werner, Susanna Price

^*Corresponding author for this work

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Abstract

There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice.

Original language	English
Pages (from-to)	E274-E286
Journal	EuroIntervention
Volume	17
Issue number	4
DOIs	https://doi.org/10.4244/eijy21m05_01
Publication status	Published - Jul 2021

Bibliographical note

Conflict of interest: A.C. received consulting fees/honoraria from Abiomed, Abbott Vascular, Cardinal Health, Biosensor, Magenta Medical. D.D. has served on the Scientific Advisory Board of Impella CP. A.C. received grants and personal fees from Getinge. J.E.M. received grants and personal fees from Abiomed and personal fees from Orion Pharma and Novartis. F.P. received personal fees from Abiomed. G.T. received personal fees from Abiomed and GADA. G.T. received personal fees from GE Healthcare. N.v.M. received grants and personal fees from Abbott Vascular, Medtronic, Boston Scientific, PulseCath BV. N.W. received personal fees and non-financial support from Abiomed. None of the other Authors has relevant conflicts of interest to disclose.
Publisher Copyright:
© Europa Digital & Publishing 2021. All rights reserved.

Access to Document

10.4244/eijy21m05_01

https://api.eurointervention.com/v1/articles/16107/download/pdf

Cite this

Chieffo, A., Dudek, D., Hassager, C., Combes, A., Gramegna, M., Halvorsen, S., Huber, K., Kunadian, V., Maly, J., Møller, J. E., Pappalardo, F., Tarantini, G., Tavazzi, G., Thiele, H., Vandenbriele, C., Van Mieghem, N., Vranckx, P., Werner, N., & Price, S. (2021). Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices. EuroIntervention, 17(4), E274-E286. https://doi.org/10.4244/eijy21m05_01

@article{ff64daceea2346a6a5315c9a37de765a,

title = "Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices",

abstract = "There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice.",

author = "Alaide Chieffo and Dariusz Dudek and Christian Hassager and Alain Combes and Mario Gramegna and Sigrun Halvorsen and Kurt Huber and Vijay Kunadian and Jiri Maly and M{\o}ller, {Jacob Eifer} and Federico Pappalardo and Giuseppe Tarantini and Guido Tavazzi and Holger Thiele and Christophe Vandenbriele and {Van Mieghem}, Nicolas and Pascal Vranckx and Nikos Werner and Susanna Price",

note = "Conflict of interest: A.C. received consulting fees/honoraria from Abiomed, Abbott Vascular, Cardinal Health, Biosensor, Magenta Medical. D.D. has served on the Scientific Advisory Board of Impella CP. A.C. received grants and personal fees from Getinge. J.E.M. received grants and personal fees from Abiomed and personal fees from Orion Pharma and Novartis. F.P. received personal fees from Abiomed. G.T. received personal fees from Abiomed and GADA. G.T. received personal fees from GE Healthcare. N.v.M. received grants and personal fees from Abbott Vascular, Medtronic, Boston Scientific, PulseCath BV. N.W. received personal fees and non-financial support from Abiomed. None of the other Authors has relevant conflicts of interest to disclose. Publisher Copyright: {\textcopyright} Europa Digital & Publishing 2021. All rights reserved.",

year = "2021",

month = jul,

doi = "10.4244/eijy21m05_01",

language = "English",

volume = "17",

pages = "E274--E286",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "4",

}

Chieffo, A, Dudek, D, Hassager, C, Combes, A, Gramegna, M, Halvorsen, S, Huber, K, Kunadian, V, Maly, J, Møller, JE, Pappalardo, F, Tarantini, G, Tavazzi, G, Thiele, H, Vandenbriele, C, Van Mieghem, N, Vranckx, P, Werner, N & Price, S 2021, 'Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices', EuroIntervention, vol. 17, no. 4, pp. E274-E286. https://doi.org/10.4244/eijy21m05_01

TY - JOUR

T1 - Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

AU - Chieffo, Alaide

AU - Dudek, Dariusz

AU - Hassager, Christian

AU - Combes, Alain

AU - Gramegna, Mario

AU - Halvorsen, Sigrun

AU - Huber, Kurt

AU - Kunadian, Vijay

AU - Maly, Jiri

AU - Møller, Jacob Eifer

AU - Pappalardo, Federico

AU - Tarantini, Giuseppe

AU - Tavazzi, Guido

AU - Thiele, Holger

AU - Vandenbriele, Christophe

AU - Van Mieghem, Nicolas

AU - Vranckx, Pascal

AU - Werner, Nikos

AU - Price, Susanna

N1 - Conflict of interest: A.C. received consulting fees/honoraria from Abiomed, Abbott Vascular, Cardinal Health, Biosensor, Magenta Medical. D.D. has served on the Scientific Advisory Board of Impella CP. A.C. received grants and personal fees from Getinge. J.E.M. received grants and personal fees from Abiomed and personal fees from Orion Pharma and Novartis. F.P. received personal fees from Abiomed. G.T. received personal fees from Abiomed and GADA. G.T. received personal fees from GE Healthcare. N.v.M. received grants and personal fees from Abbott Vascular, Medtronic, Boston Scientific, PulseCath BV. N.W. received personal fees and non-financial support from Abiomed. None of the other Authors has relevant conflicts of interest to disclose. Publisher Copyright: © Europa Digital & Publishing 2021. All rights reserved.

PY - 2021/7

Y1 - 2021/7

N2 - There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice.

AB - There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice.

UR - http://www.scopus.com/inward/record.url?scp=85111475513&partnerID=8YFLogxK

U2 - 10.4244/eijy21m05_01

DO - 10.4244/eijy21m05_01

M3 - Article

C2 - 34057071

AN - SCOPUS:85111475513

SN - 1774-024X

VL - 17

SP - E274-E286

JO - EuroIntervention

JF - EuroIntervention

IS - 4

ER -

Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this